Anima Biotech to Present at the Undruggable Leaders Forum Europe
April 08, 2021 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company...
Anima Biotech Announces Strategic Collaboration with Takeda to Discover and Develop mRNA Translation Modulators for Neurological Diseases
March 18, 2021 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company...
Anima Biotech to Present at Multiple Investor and Scientific Conferences in March
March 10, 2021 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., March 10, 2021 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company...
Anima Biotech to Present at Multiple Investor and Scientific Conferences in February
February 02, 2021 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced the company will...
Anima Biotech to Participate in the 3rd Annual RNA-Targeted Drug Discovery Conference
December 08, 2020 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced the company will...
Anima Biotech to Participate in the Cambridge Healthtech Institute’s 2nd Annual RNA as a Drug Target Conference
September 16, 2020 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced the company will...
Anima Biotech to Present at Three Upcoming Investor and Scientific Conferences in August
August 18, 2020 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced the company will...
Anima Biotech to Present at the 13th Annual European Life Sciences CEO Forum
February 17, 2020 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., Feb. 17, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that control mRNA translation, today announced the company will present at...
Anima Biotech to Present at the BIO CEO & Investor Conference
February 06, 2020 10:13 ET
|
Anima Biotech
BERNARDSVILLE, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that control mRNA translation, today announced the company will present at...
Anima Biotech to Present at the 6th Annual LSX World Congress
February 03, 2020 10:17 ET
|
Anima Biotech
BERNARDSVILLE, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that control mRNA translation, today announced the company will present at...